HEY1 and rhabdomyosarcoma: In fact, HEY1 is a candidate oncogene that is highly expressed in glioblastoma 33, 34, rhabdomyosarcoma 35, hepatocellular carcinoma 36, head and neck squamous cell carcinoma 37, and renal cell carcinoma 38, among other cancers.